← Leaderboards
Qing Ma
Washington University
$230,177
Attributed
$441,502
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $237K · FY2009–13$250K$187.5K$125K$62.5K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$441,502 · 3
By mechanism
R21$422,650 · 1
P41$18,852 · 2
Top collaborators
- Vahid Afshar-Kharghan2 shared
Most similar at Washington University
Same institution · by research overlap
- Dominic N Reeds$11,620,890
- Paul W Hruz$5,147,101
- William G. Powderly$79,446,872
- Makedonka Mitreva$12,990,587
- James W Janetka$9,104,937
Others in their field
Top investigators on “Open Label”
- Oscar R Benavente · University Of Texas Hlth Sci Ctr San Ant$62,865,512
- Adam L Boxer · Mayo Clinic Rochester$37,920,605
- Keith A. Johnson · Banner Health$37,287,435
- Mahzad Mehrinfar · Fisher Bioservices, Inc.$29,869,623
- Paul S. Aisen · Cognition Therapeutics, Inc.$25,788,543
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
Open LabelResourcesGrantNelfinavirProtease InhibitorResearch PersonnelDoseFundingHiv-1 ProteaseLinear RegressionsPlasmaProspectiveAids Clinical Trial GroupRandomizedComplexComputer Retrieval Of Information On Scientific Projects DatabaseDrug KineticsEfavirenzHealthy VolunteerCell RespirationIndinavirInstitutionAmprenavirRitonavir
Grant awards (4)
The role of complement system in alloimmune responses$185,650
R21 · FY2013 · AI · contact PI
The role of complement system in alloimmune responses$237,000
R21 · FY2012 · AI · contact PI
PHARMACOKINETIC INTERACTION BETWEEN EFAVIRENZ AND DUAL PROTEASE INHIBITORS$12,323
P41 · FY2010 · RR · contact PI
PHARMACOKINETIC INTERACTION BETWEEN EFAVIRENZ AND DUAL PROTEASE INHIBITORS$6,529
P41 · FY2009 · RR · contact PI